This Project Grant award, issued by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports research on the mechanisms linking maternal obesity and inflammatory markers to adverse pregnancy outcomes, such as preeclampsia. The overarching goal is to test the hypothesis that pro-inflammatory mediators produced by maternal adipose tissue (leptin) reduce pro-angiogenic immune cells and factors at the maternal-fetal interface, leading to abnormal placental vascular development. The $456,251 award, effective August 1, 2024, will fund a 5-year project conducted by Colorado State University. The research combines in vivo and ex vivo experiments using the BPH/5 mouse model of preeclampsia to determine if hyperleptinemia promotes decidual inflammation, identify the source of decidual inflammation and placental angiogenic deficiency, and assess whether reversal of maternal obesity prevents aberrant fetal cardiac angiogenesis and adult-onset cardiometabolic dysfunction in offspring. These findings aim to provide insights into prenatal mechanisms to prevent adult-onset cardiometabolic disease and hypertension in preeclampsia-born offspring.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| Not listed | $456.3k | 7/29/24 |